FDA Drug · D-0035-2027

Tretinoin Cream UPS, 0.05%, 20g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals USA Inc., Hawthorne, NY 10532, NDC 51672-1394-0.

Class III · Ongoing

Failed Impurities/Degradation Specifications

Advertisement
Advertisement
Affected lots / codes — check yours against thisLot # AD96196, Exp Date: 12/31/2026.
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC, Princeton, NJ
Classification
Class III (unlikely to cause harm)
Status
Ongoing
Quantity
N/A
Distribution
US Nationwide.
Recall initiated
September 25, 2026
Classified
October 8, 2026
Initiation
Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0035-2027%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →